Selected research
Market Structure
Global Pharma Grade Polyvinylpyrrolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharma Grade Polyvinylpyrrolidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma Grade Polyvinylpyrrolidone include BASF, Ashland, Boai NKY Medical Holdings, JH Nanhang Life Sciences, Chongqing Star-Tech Specialty Products, Huangshan Bonsun Pharmaceuticals, Shanghai Yuking Water Soluble Material Tech, Shanghai Qifuqing Material Technology and Jiaozuo Zhongwei Special Products Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Pharma Grade Polyvinylpyrrolidone output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Pharma Grade Polyvinylpyrrolidone by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Pharma Grade Polyvinylpyrrolidone market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharma Grade Polyvinylpyrrolidone and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharma Grade Polyvinylpyrrolidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Grade Polyvinylpyrrolidone market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharma Grade Polyvinylpyrrolidone Segment by Company
BASF
Ashland
Boai NKY Medical Holdings
JH Nanhang Life Sciences
Chongqing Star-Tech Specialty Products
Huangshan Bonsun Pharmaceuticals
Shanghai Yuking Water Soluble Material Tech
Shanghai Qifuqing Material Technology
Jiaozuo Zhongwei Special Products Pharmaceutical
CNSIG Anhui Hongsifang Fertilizer
Pharma Grade Polyvinylpyrrolidone Segment by Type
K17
K25
K30
K90
Other
Pharma Grade Polyvinylpyrrolidone Segment by Application
Oral Preparations
Injectable Preparations
Topical Preparations
Others
Pharma Grade Polyvinylpyrrolidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Grade Polyvinylpyrrolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Grade Polyvinylpyrrolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Grade Polyvinylpyrrolidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharma Grade Polyvinylpyrrolidone market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Grade Polyvinylpyrrolidone industry.
Chapter 3: Detailed analysis of Pharma Grade Polyvinylpyrrolidone market competition landscape. Including Pharma Grade Polyvinylpyrrolidone manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Pharma Grade Polyvinylpyrrolidone by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Pharma Grade Polyvinylpyrrolidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- K17
- K25
- K30
- K90
- Other
Applications
- Oral Preparations
- Injectable Preparations
- Topical Preparations
- Others
Companies covered
- BASF
- Ashland
- Boai NKY Medical Holdings
- JH Nanhang Life Sciences
- Chongqing Star-Tech Specialty Products
- Huangshan Bonsun Pharmaceuticals
- Shanghai Yuking Water Soluble Material Tech
- Shanghai Qifuqing Material Technology
- Jiaozuo Zhongwei Special Products Pharmaceutical
- CNSIG Anhui Hongsifang Fertilizer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharma Grade Polyvinylpyrrolidone Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Pharma Grade Polyvinylpyrrolidone Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Pharma Grade Polyvinylpyrrolidone Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Pharma Grade Polyvinylpyrrolidone Market Dynamics
- 2.1 Pharma Grade Polyvinylpyrrolidone Industry Trends
- 2.2 Pharma Grade Polyvinylpyrrolidone Industry Drivers
- 2.3 Pharma Grade Polyvinylpyrrolidone Industry Opportunities and Challenges
- 2.4 Pharma Grade Polyvinylpyrrolidone Industry Restraints
3 Pharma Grade Polyvinylpyrrolidone Market by Manufacturers
- 3.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Manufacturers (2021-2026)
- 3.2 Global Pharma Grade Polyvinylpyrrolidone Production by Manufacturers (2021-2026)
- 3.3 Global Pharma Grade Polyvinylpyrrolidone Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharma Grade Polyvinylpyrrolidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma Grade Polyvinylpyrrolidone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharma Grade Polyvinylpyrrolidone Manufacturers, Product Type & Application
- 3.7 Global Pharma Grade Polyvinylpyrrolidone Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma Grade Polyvinylpyrrolidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma Grade Polyvinylpyrrolidone Players Market Share by Production Value in 2025
- 3.8.3 2025 Pharma Grade Polyvinylpyrrolidone Tier 1, Tier 2, and Tier 3
4 Pharma Grade Polyvinylpyrrolidone Market by Type
- 4.1 Pharma Grade Polyvinylpyrrolidone Type Introduction
- 4.1.1 K17
- 4.1.2 K25
- 4.1.3 K30
- 4.1.4 K90
- 4.1.5 Other
- 4.2 Global Pharma Grade Polyvinylpyrrolidone Production by Type
- 4.2.1 Global Pharma Grade Polyvinylpyrrolidone Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharma Grade Polyvinylpyrrolidone Production by Type (2021-2032)
- 4.2.3 Global Pharma Grade Polyvinylpyrrolidone Production Market Share by Type (2021-2032)
- 4.3 Global Pharma Grade Polyvinylpyrrolidone Production Value by Type
- 4.3.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Type (2021-2032)
- 4.3.3 Global Pharma Grade Polyvinylpyrrolidone Production Value Market Share by Type (2021-2032)
5 Pharma Grade Polyvinylpyrrolidone Market by Application
- 5.1 Pharma Grade Polyvinylpyrrolidone Application Introduction
- 5.1.1 Oral Preparations
- 5.1.2 Injectable Preparations
- 5.1.3 Topical Preparations
- 5.1.4 Others
- 5.2 Global Pharma Grade Polyvinylpyrrolidone Production by Application
- 5.2.1 Global Pharma Grade Polyvinylpyrrolidone Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharma Grade Polyvinylpyrrolidone Production by Application (2021-2032)
- 5.2.3 Global Pharma Grade Polyvinylpyrrolidone Production Market Share by Application (2021-2032)
- 5.3 Global Pharma Grade Polyvinylpyrrolidone Production Value by Application
- 5.3.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Application (2021-2032)
- 5.3.3 Global Pharma Grade Polyvinylpyrrolidone Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 BASF
- 6.1.1 BASF Company Information
- 6.1.2 BASF Business Overview
- 6.1.3 BASF Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.1.4 BASF Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.1.5 BASF Recent Developments
- 6.2 Ashland
- 6.2.1 Ashland Company Information
- 6.2.2 Ashland Business Overview
- 6.2.3 Ashland Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.2.4 Ashland Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.2.5 Ashland Recent Developments
- 6.3 Boai NKY Medical Holdings
- 6.3.1 Boai NKY Medical Holdings Company Information
- 6.3.2 Boai NKY Medical Holdings Business Overview
- 6.3.3 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.3.4 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.3.5 Boai NKY Medical Holdings Recent Developments
- 6.4 JH Nanhang Life Sciences
- 6.4.1 JH Nanhang Life Sciences Company Information
- 6.4.2 JH Nanhang Life Sciences Business Overview
- 6.4.3 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.4.4 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.4.5 JH Nanhang Life Sciences Recent Developments
- 6.5 Chongqing Star-Tech Specialty Products
- 6.5.1 Chongqing Star-Tech Specialty Products Company Information
- 6.5.2 Chongqing Star-Tech Specialty Products Business Overview
- 6.5.3 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.5.4 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.5.5 Chongqing Star-Tech Specialty Products Recent Developments
- 6.6 Huangshan Bonsun Pharmaceuticals
- 6.6.1 Huangshan Bonsun Pharmaceuticals Company Information
- 6.6.2 Huangshan Bonsun Pharmaceuticals Business Overview
- 6.6.3 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.6.4 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.6.5 Huangshan Bonsun Pharmaceuticals Recent Developments
- 6.7 Shanghai Yuking Water Soluble Material Tech
- 6.7.1 Shanghai Yuking Water Soluble Material Tech Company Information
- 6.7.2 Shanghai Yuking Water Soluble Material Tech Business Overview
- 6.7.3 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.7.4 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.7.5 Shanghai Yuking Water Soluble Material Tech Recent Developments
- 6.8 Shanghai Qifuqing Material Technology
- 6.8.1 Shanghai Qifuqing Material Technology Company Information
- 6.8.2 Shanghai Qifuqing Material Technology Business Overview
- 6.8.3 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.8.4 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.8.5 Shanghai Qifuqing Material Technology Recent Developments
- 6.9 Jiaozuo Zhongwei Special Products Pharmaceutical
- 6.9.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information
- 6.9.2 Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
- 6.9.3 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.9.4 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.9.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
- 6.10 CNSIG Anhui Hongsifang Fertilizer
- 6.10.1 CNSIG Anhui Hongsifang Fertilizer Company Information
- 6.10.2 CNSIG Anhui Hongsifang Fertilizer Business Overview
- 6.10.3 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Production, Value and Gross Margin (2021-2026)
- 6.10.4 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.10.5 CNSIG Anhui Hongsifang Fertilizer Recent Developments
7 Global Pharma Grade Polyvinylpyrrolidone Production by Region
- 7.1 Global Pharma Grade Polyvinylpyrrolidone Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Pharma Grade Polyvinylpyrrolidone Production by Region (2021-2032)
- 7.2.1 Global Pharma Grade Polyvinylpyrrolidone Production by Region (2021-2026)
- 7.2.2 Global Pharma Grade Polyvinylpyrrolidone Production Forecast by Region (2027-2032)
- 7.3 Global Pharma Grade Polyvinylpyrrolidone Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Pharma Grade Polyvinylpyrrolidone Production Value by Region (2021-2032)
- 7.4.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Region (2021-2026)
- 7.4.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Region (2027-2032)
- 7.5 Global Pharma Grade Polyvinylpyrrolidone Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Pharma Grade Polyvinylpyrrolidone Production Value (2021-2032)
- 7.6.2 Europe Pharma Grade Polyvinylpyrrolidone Production Value (2021-2032)
- 7.6.3 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Production Value (2021-2032)
- 7.6.4 South America Pharma Grade Polyvinylpyrrolidone Production Value (2021-2032)
- 7.6.5 Middle East & Africa Pharma Grade Polyvinylpyrrolidone Production Value (2021-2032)
8 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region
- 8.1 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region (2021-2032)
- 8.2.1 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region (2021-2026)
- 8.2.2 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Pharma Grade Polyvinylpyrrolidone Value Chain Analysis
- 9.1.1 Pharma Grade Polyvinylpyrrolidone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharma Grade Polyvinylpyrrolidone Production Mode & Process
- 9.2 Pharma Grade Polyvinylpyrrolidone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharma Grade Polyvinylpyrrolidone Distributors
- 9.2.3 Pharma Grade Polyvinylpyrrolidone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst